Document:

Exhibit
10.1

 

Distribution
Agreement

 

This
Distribution Agreement (this “Agreement”), dated as of February 1, 2021, is entered into between Tauriga Sciences,
Inc., a Florida corporation (“Seller”) and Bozzuto’s Inc., a Connecticut corporation, through its Stock
Up Express division (“Distributor,” and together with Seller, the “Parties,” and each, a
“Party”).

 

WHEREAS,
Seller is in the business of producing and selling the Goods (as defined below); and

 

WHEREAS,
Distributor is in the business of marketing and reselling Goods;

 

WHEREAS,
Seller desires to sell the Goods to Distributor and appoint Distributor as a non-exclusive distributor under the terms and conditions
of this Agreement; and

 

WHEREAS,
Distributor desires to purchase the Goods from Seller and resell the Goods to customers, subject to the terms and conditions of
this Agreement,

 

NOW,
THEREFORE, in consideration of the mutual covenants, terms and conditions set out herein, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:

 

1.
Definitions.

 

“Agreement”
has the meaning set out in the preamble and includes all schedules and exhibits hereto.

 

“Confidential
Information” has the meaning set out under Section 11.

 

“Customer”
means a purchaser that is an individual or entity located in the Territory and has acquired a Good from Distributor for (a) its
own internal use or incorporation into its own products or (b) resale to a person or entity that purchases the Good for internal
use or incorporation into such repurchaser’s products.

 

“Distributor”
has the meaning set out in the preamble.

 

“Force
Majeure Event” has the meaning set out in Section 36.

 

“Goods”
means any good that is identified in Schedule 1, as it may be revised pursuant to Section 4.4 from time to time.

 

“Indemnified
Party” has the meaning set out under Section 14.

 

“Party”
has the meaning set out in the preamble.

 

“Seller”
has the meaning set out in the preamble.

 

“Term”
has the meaning set out under Section 10.

 

    	 

    	 

    

 

“Territory”
means all geographic areas in the United States in which Distributor currently sells Goods (as set forth in Schedule 3 to this
Agreement), and in which it may in the future sell Goods.

 

2.
Appointment.

 

2.1
Non-Exclusive Appointment; Compliance with Law. Seller hereby appoints Distributor, and Distributor hereby accepts the
appointment, to act as a non-exclusive distributor of Goods to Customers during the Term in accordance with the terms and conditions
of this Agreement. Distributor shall not sell or offer to sell Goods outside the Territory. Seller may in its sole discretion
sell the Goods to any other person, including distributors, retailers, and customers in and outside the Territory. By accepting
this appointment, Distributor agrees to conform to all quality standards established from time to time by Seller for its distributors.
Distributor shall be solely responsible for complying with the laws and regulations applicable in the Territory in which it engages
in business in performing its responsibilities hereunder. Distributor will bear all expenses and costs related to compliance with
such laws and regulations.

 

3.
Facilities, Inventory, and Marketing Obligations.

 

3.1
Distributor Obligations. Distributor shall:

 

(a)
market, advertise, promote, and sell the Goods to Customers in a manner that reflects favorably at all times on Goods and the
good name, goodwill and reputation of Seller and consistent with good business practice, in each case using its best efforts to
maximize the sales volume of the Goods;

 

(b)
maintain a place or places of business in the Territory, or in such place as shall ensure efficient processing of orders for and
to the Customers, including adequate office, storage, and warehouse facilities and all other facilities as required for Distributor
to perform its duties under this Agreement;

 

(c)
purchase and maintain at all times a representative quantity of each Good sufficient for and consistent with the Distributor’s
Customers’ sales needs;

 

(d)
have sufficient knowledge of the industry and products competitive with each Good (including features and benefits) so as to be
able to explain in sufficient detail to Customers the differences between the Good and competing products;

 

(e)
maintain a sales and marketing organization sufficient to maximize the market potential for the sale of the Goods, and to facilitate
for prompt shipment by Distributor to each Customer upon receipt of order;

 

(f)
share its marketing plan with Seller, and to accommodate such reasonable modifications thereto as the Seller may request;

 

    	2

    	 

    

 

(g)
not make any materially misleading or untrue statements concerning Seller or the Goods, including any product disparagement or
promotions or sales of Goods by persons or entities that are competitors of Seller in the Territory;

 

(h)
promptly notify Seller of any complaint or adverse claim about any Good or its use of which Distributor becomes aware;

 

(i)
if requested by Seller, provide monthly (or if more practicable, quarterly) reports regarding inventory, marketing, and sales
of the Goods in a computer-readable format and containing the scope of information acceptable to Seller, maintain records, and
accounts of all transactions; and

 

(j)
not resell Goods to any federal, state, local, or foreign government or political subdivision or agency thereof, without express
written approval from Seller;

 

3.2
Seller Obligations. Seller shall:

 

(a)
Fulfil orders for Goods on a commercially reasonable timely basis as and when placed by Distributor;

 

(b)
provide any information and support that may be reasonably requested by Distributor regarding the marketing, advertising, promotion,
and sale of Goods;

 

(c)
allow Distributor to participate, at its own expense, in any marketing, advertising, promotion and sales programs or events that
Seller may make generally available to its authorized distributors of Goods in the Territory, provided that Seller may alter or
eliminate any program at any time;

 

(d)
approve or reject, in its discretion, any promotional information or material submitted by Distributor for Seller’s approval;
and

 

(e)
in Seller’s discretion provide promotional information and material free of charge to Distributor for use by Distributor
in accordance with this Agreement.

 

4.
Agreement to Purchase and Sell Goods.

 

4.1
Terms of Sale; Orders. Seller shall make available and sell Goods to Distributor at the prices under Section 4.2 and on
the terms and conditions set out in this Agreement.

 

4.2
Price. The prices for Goods sold by Seller to Distributor under this Agreement shall be as set forth in Schedule 1, Seller’s
then-current wholesale price list Seller shall have the right at any time upon thirty (30) days prior written notice to revise
the prices set forth in Schedule 1. All prices are in U.S. dollars. Subject to Section 6:

 

(a)
all prices are exclusive of all sales, use and excise taxes, and any other similar taxes, duties, and charges of any kind imposed
by any governmental authority on any amounts payable by Distributor under this Agreement; and

 

    	3

    	 

    

 

(b)
Distributor shall bear and be responsible for: (i) the payment of all taxes in the Territory associated with the purchase of any
Goods (other than taxes based on Seller’s net income) fees, duties, or other amounts, however designated, including value
added and withholding taxes which are levied or based upon such charges, or upon this Agreement. Taxes related to Goods purchased
pursuant to this Agreement shall be paid by Distributor or Distributor shall present an exemption certificate acceptable to the
taxing authorities; and (ii) keeping all records and/or impounding or paying all taxes (e.g., national, local, self employment
tax, foreign tax withholding, etc.) and any other charges required by and imposed by any taxing authority on payments to Distributor’s
employees or agents.

 

(c)
Distributor shall perform its obligations under this Agreement without setoff, deduction, recoupment or withholding of any kind
for amounts owed or payable by Seller, whether under this Agreement, any purchase order, any other agreement between (i) Distributor
or any of its affiliates and (ii) Seller or any of its affiliates, or otherwise.

 

4.3
Payment Terms. Seller shall issue invoices (for the wholesale price set forth in Schedule 1) to Distributor on a
monthly basis for all Goods ordered in the previous calendar month. Distributor shall pay all properly invoiced amounts due to
Seller within thirty (30) calendar days after Distributor’s receipt of such invoice, except for any amounts disputed by
Distributor in good faith.

 

Distributor
shall make all payments in U.S. dollars by check, wire transfer, or automated clearing house, in accordance with the payment/wire
instructions set forth in Schedule 4 to this Agreement:

 

4.4
Availability/Changes in Goods. Seller may, in its sole discretion, add or make changes to Goods or remove Goods from Schedule
1 on thirty (30) days prior written notice to Distributor, in each case, without obligation to modify or change any Goods
previously delivered or to supply new goods meeting earlier specifications.

 

5.
Orders Procedure.

 

5.1
Orders. Distributor shall issue all purchase orders to Seller in written form via facsimile or e-mail, or by overnight
courier (with email notice simultaneous with such courier delivery). By placing an order, Distributor makes an offer to purchase
Goods under the following commercial terms listed in the purchase order and the terms and conditions of this Agreement, and on
no other terms:

 

(a)
the listed Goods to be purchased;

 

(b)
the quantities ordered; and

 

(c)
the requested delivery date.

 

Any
variations made to the terms and conditions of this Agreement by Distributor in any order are void and shall have no effect.

 

    	4

    	 

    

 

5.2
Seller’s Right to Accept or Reject Orders. Seller may accept any order by confirming the order (whether by written
confirmation, invoice, or otherwise) or by delivering the Goods, whichever occurs first. If Seller does not accept the order under
the terms of this Section 5.2 within twenty (20) calendar days of Seller’s receipt of the order, the order will lapse. No
order is binding on either Party unless pursuant to the terms of this Agreement.

 

6.
Shipment and Delivery.

 

6.1
Shipment and Delivery. Unless expressly agreed to by the Parties in writing, Seller shall:

 

(a)
Select the method of shipment of and the carrier for the Goods for delivery to Distributor. Seller may, in its sole discretion,
without liability or penalty, make partial shipments of Goods, each of which constitutes a separate sale and Distributor shall
pay for the units shipped.

 

(b)
Deliver the Goods to the location indicated by Distributor on each Order placed by it using Seller’s or manufacturer’s
standard methods for packaging and shipping.

 

6.2
Title and Risk of Loss. Title and risk of loss passes to Distributor upon delivery of the Goods at the location indicated
by Distributor on each Order placed by it.

 

6.3
Inspection and Acceptance of Goods. Distributor shall inspect Goods received under this Agreement. On the 3rd
after delivery of the Goods, Distributor shall be deemed to have accepted the Goods unless it earlier notifies Seller in writing
and furnishes written evidence or other documentation as reasonably required by Seller that the Goods:

 

(a)
are damaged, defective, or otherwise do not conform to the Distributor’s applicable purchase order; or

 

(b)
were delivered to Distributor as a result of Seller’s error.

 

If
Distributor notifies Seller pursuant to this Section 6.3, then Seller shall determine, in its sole discretion, whether to repair
or replace the Goods or refund the wholesale price (set forth in Schedule 1) for the Goods.

 

Distributor
shall ship at Seller’s expense, all goods to be returned or replaced under this Section 6.3 to such facility as Seller shall
provide. If Seller exercises its option to replace the Goods, Seller shall, after receiving Distributor’s shipment of the
Goods under this provision, ship to Distributor, at Seller’s expense, the replacement Goods to the location requested by
Distributor . Distributor acknowledges and agrees that the remedies set out in this Section 6.3 are exclusive of all other remedies,
subject to Distributor’s rights regarding any Goods for which Distributor has accepted delivery under this Section 6.3.

 

7.
Seller’s Trademark License Grant.
Subject to the terms and conditions of this Agreement, Seller hereby grants to Distributor a non-exclusive, non-transferable,
and non-sublicensable license in the Territory during the Term solely on or in connection with the promotion, advertising, and
resale of the Goods in accordance with the terms and conditions of this Agreement to use all Seller’s trademarks set forth
on Schedule 2, whether registered or unregistered, including the listed registrations and applications and any registrations,
which may be granted pursuant to such applications. On expiration or earlier termination of this Agreement or upon Seller request,
Distributor shall promptly discontinue the display or use of any trademark or service mark or change the manner in which it is
displayed or used with regard to the Goods. Upon expiration or earlier termination of this Agreement, Distributor’s rights
under this Section 7 shall cease immediately. Other than the express licenses granted by this Section 7, Seller
grants no right or license to Distributor, by implication, estoppels, or otherwise, to the Goods or any intellectual property
rights of Seller or its affiliates.

 

    	5

    	 

    

 

8.
Resale Prices.
Distributor shall establish the resale prices and terms regarding the Goods, which shall be in its sole discretion, but which
shall not be set at such prices which materially undercut Seller’s other selling efforts.

 

9.
[Reserved]

 

10.
Term; Termination.

 

10.1
Term. The term of this Agreement commences on the date set out in the preamble of this Agreement and shall remain effective
for a period of two (2) years thereafter, and shall automatically renew for additional successive one (1) year terms unless and
until either Party to this Agreement provides prior written notice of nonrenewal at least thirty (30) days before the end of the
then-current term, or unless and until earlier terminated as provided under this Agreement or applicable law (the “Term”).
If either Party/Seller provides timely notice of its intent not to renew this Agreement, then unless earlier terminated in accordance
with its terms, this Agreement terminates on the expiration of the then-current Term.

 

10.2
Termination for Cause. Either Party has the right to terminate this Agreement if the other party breaches or is in default
of any obligation hereunder, including the failure to make any payment when due, which default is incapable of cure or which,
being capable of cure, has not been cured within thirty (30) days after receipt of written notice from the non-defaulting Party
or within such additional cure period as the non-defaulting Party may authorize in writing.

 

10.3
Termination for Convenience. Either Party may terminate this Agreement for convenience by giving a sixty (60) day written
notice to the other Party.

 

10.4
Termination for Bankruptcy. Seller may terminate this Agreement upon the filing by or against Distributor of any action
under any federal, state or other applicable bankruptcy or insolvency law, which is not dismissed or otherwise favorably resolved
within thirty (30) days of such event.

 

10.5
Additional Cause for Termination. In addition to the aforementioned, Seller may terminate this Agreement with immediate
effect if Distributor: (a) fails to secure or renew any license, permit authorization or approval for the conduct of its business
with respect to the Goods; or (b) challenges, assists a third party in challenging, or fails to assist Seller in enforcing Seller’s
right, title or interest in and to Seller’s intellectual property asserted in this Agreement.

 

    	6

    	 

    

 

10.6
Effect of Expiration or Termination. Upon the expiration or earlier termination of this Agreement: (a) all related purchase
orders are automatically terminated; and (b) Distributor shall cease to represent itself as Seller’s authorized distributor
regarding the Goods, and shall otherwise desist from all conduct or representations that might lead the public to believe that
Distributor is authorized by Seller to sell the Goods. Upon the effective date of expiration or earlier termination of this Agreement,
Seller shall have the right, but not the obligation, to buy back all or a portion of such Goods, free of all liens, claims or
encumbrances, at a price equal to the Distributor’s cost paid to Seller. Except as otherwise expressly provided herein,
upon the expiration or termination of this Agreement Distributor shall not be entitled to, and to the fullest extent permitted
by law waives, any statutorily prescribed or other compensation, reimbursement or damages for loss of goodwill, clientele, prospective
profits, investments or anticipated sales or commitments of any kind.

 

11.
Confidential Information.
All non-public, confidential or proprietary information of the Parties, including, but not limited to, specifications, samples,
patterns, designs, plans, drawings, documents, data, business operations, customer lists, pricing, discounts or rebates, disclosed
by either Party to the other Party, whether disclosed orally or disclosed or accessed in written, electronic or other form or
media, and whether or not marked, designated or otherwise identified as “confidential,” in connection with this Agreement
is confidential, solely for the use of performing this Agreement and may not be disclosed or copied unless authorized by such
disclosing Party in writing. Upon a disclosing Party’s request, the other Party shall promptly return all documents and
other materials received from disclosing Party. The Parties shall be entitled to injunctive relief for any violation of this Section.
This Section shall not apply to information that is:

 

(a)
in the public domain;

 

(b)
known to Distributor at the time of disclosure; or

 

(c)
rightfully obtained by Distributor on a non-confidential basis from a third party.

 

12.
EXCEPT FOR THE WARRANTIES SET OUT UNDER SECTION 12, NEITHER SELLER NOR ANY PERSON ON SELLER’S BEHALF HAS MADE OR MAKES FOR
DISTRIBUTOR’S BENEFIT ANY EXPRESS OR IMPLIED REPRESENTATION OR WARRANTY WHATSOEVER, INCLUDING ANY WARRANTIES OF: (i) MERCHANTABILITY;
(ii) FITNESS FOR A PARTICULAR PURPOSE; (iii) TITLE; OR (iv) NON-INFRINGEMENT; WHETHER ARISING BY LAW, COURSE OF DEALING, COURSE
OF PERFORMANCE, USAGE OF TRADE OR OTHERWISE, ALL OF WHICH ARE EXPRESSLY DISCLAIMED. DISTRIBUTOR ACKNOWLEDGES THAT IT HAS NOT RELIED
ON ANY REPRESENTATION OR WARRANTY MADE BY SELLER, OR ANY OTHER PERSON ON SELLER’S BEHALF.

 

    	7

    	 

    

 

13.
Compliance with Laws. Distributor shall
at all times comply with all federal, state and local laws, ordinances, regulations and orders that are applicable to the operation
of its business, and this Agreement and its performance hereunder.

 

14.
Indemnification. Subject to the terms
and conditions of this Agreement, Distributor shall indemnify, hold harmless, and defend Seller and its officers, directors, partners,
shareholders, employees, agents, affiliates, successors, and permitted assigns (collectively, “Indemnified Party”)
against any and all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties,
fines, costs, or expenses of whatever kind, including attorneys’ fees, fees, and the costs of enforcing any right to indemnification
under this Agreement and the cost of pursuing any insurance providers, relating to any claim of a third party or Seller arising
out of or occurring in connection with: (i) Distributor’s modification, use or distribution of the Seller’s Goods
not in strict accordance with this Agreement; (ii) any misrepresentation or any breach of any warranty, covenant or agreement
on the part of Distributor; or (iii) any third party claim or action against Seller for injuries or damage to persons or property
caused or claimed to have been caused by the negligent acts or omissions of Distributor personnel while in the course of performing
work under this Agreement.

 

15.
Limitation of Liability. EXCEPT FOR OBLIGATIONS
UNDER THIS AGREEMENT, LIABILITY FOR INDEMNIFICATION, LIABILITY FOR BREACH OF CONFIDENTIALITY, OR LIABILITY FOR INFRINGEMENT OR
MISAPPROPRIATION OF INTELLECTUAL PROPERTY RIGHTS, IN NO EVENT:

 

(a)
IS SELLER OR ANY SELLER REPRESENTATIVE LIABLE FOR CONSEQUENTIAL, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, PUNITIVE, OR ENHANCED
DAMAGES, LOST PROFITS OR REVENUES, OR DIMINUTION IN VALUE, ARISING OUT OF OR RELATING TO ANY BREACH OF THIS AGREEMENT, REGARDLESS
OF:

 

(i)
WHETHER THE DAMAGES WERE FORESEEABLE;

 

(ii)
WHETHER OR NOT SELLER WAS ADVISED OF THE POSSIBILITY OF THE DAMAGES; AND

 

(iii)
THE LEGAL OR EQUITABLE THEORY (CONTRACT, TORT, OR OTHERWISE) ON WHICH THE CLAIM IS BASED.

 

(b)
SHALL SELLER’S AGGREGATE LIABILITY ARISING OUT OF OR RELATED TO THIS AGREEMENT, WHETHER ARISING OUT OF OR RELATED TO BREACH
OF CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE, EXCEED THE AMOUNTS PAID AND AMOUNTS ACCRUED BUT NOT YET PAID TO SELLER
UNDER THIS AGREEMENT IN THE ONE YEAR PERIOD PRECEDING THE EVENT GIVING RISE TO THE CLAIM.

 

    	8

    	 

    

 

16.
THE FOREGOING LIMITATIONS APPLY EVEN IF THE DISTRIBUTOR’S REMEDIES UNDER THIS AGREEMENT FAIL OF THEIR ESSENTIAL PURPOSE.

 

17.
Entire Agreement.
This Agreement, including and together with any related exhibits, schedules, attachments and appendices, constitutes the sole
and entire agreement of the Parties with respect to the subject matter contained herein, and supersedes all prior and contemporaneous
understandings, agreements, representations, and warranties, both written and oral, regarding such subject matter. The terms of
this Agreement prevail over any terms or conditions contained in any other documentation related to the subject matter of this
Agreement and expressly exclude any of Distributor’s general terms and conditions contained in any purchase order or other
document issued by Distributor (excluding the information set out in Section 5.1(a) - Section 5.1(c)).

 

18.
Survival.
Subject to the limitations and other provisions of this Agreement: (a) the representations and warranties of the Parties contained
herein shall survive the expiration or earlier termination of this Agreement; and (b) Sections 1, 7, 8, 10, 11, 14, 15, 17, 23
of this Agreement, as well as any other provision that, in order to give proper effect to its intent, should survive such expiration
or termination, shall survive the expiration or earlier termination of this Agreement. All other provisions of this Agreement
shall not survive the expiration or earlier termination of this Agreement.

 

19.
Notices.
All notices, requests, consents, claims, demands, waivers and other communications under this Agreement must be in writing and
addressed to the other Party at its address set forth below (or to such other address that the receiving Party may designate from
time to time in accordance with this Section). Unless otherwise agreed herein, all notices must be delivered by personal delivery,
nationally recognized overnight courier, or certified or registered mail (in each case, return receipt requested and postage prepaid).
Except as otherwise provided in this Agreement, a notice is effective only (a) on receipt by the receiving Party, and (b) if the
Party giving the notice has complied with the requirements of this Section.

 

	Notice
    to Seller:	4
    Nancy Court, Suite # 4, Wappingers Falls, NY 12590
	 	Attention:
Chief Executive Officer

        Seller
        Email: Sshaw@tauriga.com

	 	 
	Notice
    to Distributor:	275
Schoolhouse Road

        Cheshire,
        CT 06410

	 	Attention:
Vice President of Technology/Ecommerce

        Distributor
        Email: smethvin@bozzutos.com

 

20.
Severability.
If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality,
or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such
term or provision in any other jurisdiction.

 

    	9

    	 

    

 

21.
Amendments; Waiver.
No amendment to or waiver of this Agreement is effective unless it is in writing and signed by an authorized representative of
each Party. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy
or privilege under this Agreement shall operate or be construed as a waiver thereof.

 

22.
Cumulative Remedies.
All rights and remedies provided in this Agreement are cumulative and not exclusive, and the exercise by either Party of any right
or remedy does not preclude the exercise of any other rights or remedies that may now or subsequently be available at law, in
equity, by statute, in any other agreement between the Parties, or otherwise. Notwithstanding the previous sentence, the Parties
intend that Distributor’s rights under Section 6.3 are Distributor’s exclusive remedies for the events specified therein.

 

23.
Independent Contractors. The relationship of Seller and Distributor established by this Agreement is that of independent
contractors, and nothing contained in this Agreement shall be construed: (i) to give either Party the power to direct or control
the day-to-day activities of the other, or (ii) to constitute the Parties as partners, joint venturers, co-owners or otherwise
as participants in a joint or common undertaking. Seller is in no manner associated with or otherwise connected with the actual
performance of this Agreement on the part of Distributor, nor with Distributor’s employment of other persons or incurring
of other expenses. 

 

24.
Publicity. Subject to the terms of this Agreement, neither Party hereto shall issue any press release or make any public
announcement regarding this Agreement or the matters contemplated hereby without the prior written consent (not to be unreasonably
withheld) of the other Party (which consent may be provided via email). Notwithstanding the foregoing, Distributor agrees and
acknowledges that Seller is a publicly reporting company under the Securities Act of 1934, as amended, and is required to make
certain disclosures in its SEC filings, which Seller will provide to Distributor in advance of such initial disclosure (solely
relating to this Agreement), but which will not be required to be provided to Distributor each time such disclosure is included
in subsequent SEC filings by Seller thereafter.

 

25.
Assignment. Distributor shall not assign,
transfer, delegate, or subcontract any of its rights or obligations under this Agreement without the prior written consent of
Seller.

 

26.
Successors and Assigns. This Agreement
is binding on and inures to the benefit of the Parties to this Agreement and their respective permitted successors and permitted
assigns.

 

27.
No Third-Party Beneficiaries. Subject
to the next paragraph, this Agreement benefits solely the Parties to this Agreement and their respective permitted successors
and assigns and nothing in this Agreement, express or implied, confers on any other Person (including any Customer) any legal
or equitable right, benefit, or remedy of any nature whatsoever under or by reason of this Agreement.

 

28.
The Parties hereby designate Indemnified Parties as third-party beneficiaries of Section 17 with the right to enforce this provision.

 

29.
Choice of Law. This Agreement, including
all exhibits, schedules, attachments and appendices attached to this Agreement and thereto, and all matters arising out of or
relating to this Agreement, are governed by, and construed in accordance with, the laws of the State of New York, United States
of America, without regard to the conflict of laws provisions thereof to the extent such principles or rules would require or
permit the application of the laws of any jurisdiction other than those of the State of New York.

 

    	10

    	 

    

 

30.
Choice of Forum. Each Party irrevocably
and unconditionally agrees that it will not commence any action, litigation, or proceeding of any kind whatsoever against the
other Party in any way arising from or relating to this Agreement, including all exhibits, schedules, attachments, and appendices
attached to this Agreement, and all contemplated transactions in any forum other than the U.S. District Court for the Southern
District of New York or the courts of the State of New York sitting in New York County, NY, and any appellate court from any thereof.
Each Party irrevocably and unconditionally submits to the exclusive jurisdiction of such courts. Each Party agrees that a final
judgment in any such action, litigation, or proceeding is conclusive and may be enforced in other jurisdictions by suit on the
judgment or in any other manner provided by law.

 

31.
Waiver of Jury Trial.
Each Party acknowledges and agrees that each such Party irrevocably and unconditionally
waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Agreement, including
any exhibits, schedules, attachments, or appendices attached to this Agreement, or the transactions contemplated hereby.

 

32.
Counterparts.
This Agreement may be executed in counterparts, each of which is deemed an original, but all of which together are deemed to be
one and the same agreement. Notwithstanding anything to the contrary herein, a signed copy of this Agreement delivered by facsimile,
email, or other means of electronic transmission is deemed to have the same legal effect as delivery of an original signed copy
of this Agreement.

 

33.
Force Majeure. No Party shall be liable
or responsible to the other Party, nor be deemed to have defaulted under or breached this Agreement, for any failure or delay
in fulfilling or performing any term of this Agreement (except for any obligations to make payments to the other Party under this
Agreement), when and to the extent the failure or delay is caused by or results from acts beyond the impacted Party’s (“Impacted
Party”) reasonable control (which events may include natural disasters, embargoes, explosions, riots, wars or acts of invasion
or terrorism, requirements of law, national or regional emergency or shortage of adequate power or transportation) (each, a “Force
Majeure Event”). A Party shall give the other Party prompt written notice of any event or circumstance that is reasonably
likely to result in a Force Majeure Event, and the anticipated duration of such Force Majeure Event. An affected Party shall use
all diligent efforts to end the Force Majeure Event, ensure that the effects of any Force Majeure Event are minimized, and resume
full performance under this Agreement.

 

[signature
page follows]

 

    	11

    	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first written above by their respective
officers thereunto duly authorized.

 

	 	Tauriga
    Sciences, Inc.
	 	 	 
	 	By	 
	 	Name:
    	Seth
    M. Shaw
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	Bozzuto’s
    Inc.
	 	 	 
	 	By	 
	 	Name:	 
	 	Title:	 

 

    	12Exhibit
4.1

 

NEITHER
THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE
COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT
OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO,
THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND
THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN
SECURED BY SUCH SECURITIES.

 

COMMON
STOCK PURCHASE WARRANT

 

Citius
Pharmaceuticals, Inc.

 

 

	Warrant Shares: _______	Issue Date: January ___,
    2021
	 	Initial Exercise
    Date: January __, 2021

 

THIS
COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns
(the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter
set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to
5:00 p.m. (New York City time) on [__]1 (the “Termination Date”) but not thereafter, to subscribe
for and purchase from Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares
(as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share
of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

 

Section
1.Definitions. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that
certain Securities Purchase Agreement (the “Purchase Agreement”), dated January 24, 2021, among the Company and the
purchasers signatory thereto.

 

 

 

 

 

1
The date that is the five and one-half (5.5) year anniversary of the Initial Exercise Date, provided that, if such date
is not a Trading Day, insert the immediately following Trading Day.

 

    1

     

    

 

Section
2.Exercise.

 

a)
Exercise of Warrant. Exercise of the purchase rights represented by this Warrant may be made, in whole or in part, at any
time or times on or after the Initial Exercise Date and on or before the Termination Date by delivery to the Company of a duly
executed facsimile copy or PDF copy submitted by e-mail (or e-mail attachment) of the Notice of Exercise in the form annexed hereto
(the “Notice of Exercise”). Within the earlier of (i) two (2) Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period (as defined in Section 2(d)(i) herein) following the date of exercise as aforesaid,
the Holder shall deliver the aggregate Exercise Price for the Warrant Shares specified in the applicable Notice of Exercise by
wire transfer or cashier’s check drawn on a United States bank unless the cashless exercise procedure specified in Section
2(c) below is specified in the applicable Notice of Exercise. No ink-original Notice of Exercise shall be required, nor shall
any medallion guarantee (or other type of guarantee or notarization) of any Notice of Exercise be required. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company until the Holder
has purchased all of the Warrant Shares available hereunder and the Warrant has been exercised in full, in which case, the Holder
shall surrender this Warrant to the Company for cancellation within three (3) Trading Days of the date on which the final Notice
of Exercise is delivered to the Company. Partial exercises of this Warrant resulting in purchases of a portion of the total number
of Warrant Shares available hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable hereunder
in an amount equal to the applicable number of Warrant Shares purchased. The Holder and the Company shall maintain records showing
the number of Warrant Shares purchased and the date of such purchases. The Company shall deliver any objection to any Notice of
Exercise within one (1) Trading Day of receipt of such notice. The Holder and any assignee, by acceptance of this Warrant,
acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant
Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount
stated on the face hereof.

 

b)
Exercise Price. The exercise price per share of Common Stock under this Warrant shall be $1.231, subject to adjustment
hereunder (the “Exercise Price”).

 

c)
Cashless Exercise. If at the time of exercise hereof there is no effective registration statement registering, or the prospectus
contained therein is not available for the resale of the Warrant Shares by the Holder, then this Warrant may also be exercised,
in whole or in part, at such time by means of a “cashless exercise” in which the Holder shall be entitled to receive
a number of Warrant Shares equal to the quotient obtained by dividing [(A-B) (X)] by (A), where:

 

(A)
=   as applicable: (i) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise if such Notice
of Exercise is (1) both executed and delivered pursuant to Section 2(a) hereof on a day that is not a Trading Day or (2) both
executed and delivered pursuant to Section 2(a) hereof on a Trading Day prior to the opening of “regular trading hours”
(as defined in Rule 600(b)(68) of Regulation NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the
option of the Holder, either (y) the VWAP on the Trading Day immediately preceding the date of the applicable Notice of Exercise
or (z) the Bid Price of the Common Stock on the principal Trading Market as reported by Bloomberg L.P. as of the time of the Holder’s
execution of the applicable Notice of Exercise if such Notice of Exercise is executed during “regular trading hours”
on a Trading Day and is delivered within two (2) hours thereafter (including until two (2) hours after the close of “regular
trading hours” on a Trading Day) pursuant to Section 2(a) hereof or (iii) the VWAP on the date of the applicable Notice
of Exercise if the date of such Notice of Exercise is a Trading Day and such Notice of Exercise is both executed and delivered
pursuant to Section 2(a) hereof after the close of “regular trading hours” on such Trading Day;

    2

     

    

 

(B)
=    the Exercise Price of this Warrant, as adjusted hereunder; and

 

(X)
=   the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant
if such exercise were by means of a cash exercise rather than a cashless exercise.

 

“Bid
Price” means, for any date, the price determined by the first of the following clauses that applies: (a) if the Common
Stock is then listed or quoted on a Trading Market, the bid price of the Common Stock for the time in question (or the nearest
preceding date) on the Trading Market on which the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based
on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading
Market, the volume weighted average price of the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX
as applicable, (c) if the Common Stock is not then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common
Stock are then reported on The Pink Open Market (or a similar organization or agency succeeding to its functions of reporting
prices), the most recent bid price per share of the Common Stock so reported, or (d) in all other cases, the fair market value
of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holders of a majority in interest
of the Securities then outstanding and reasonably acceptable to the Company, the fees and expenses of which shall be paid by the
Company.

 

“VWAP”
means, for any date, the price determined by
the first of the following clauses that applies: (a) if the Common Stock is then listed or quoted on a Trading Market, the daily
volume weighted average price of the Common Stock for such date (or the nearest preceding date) on the Trading Market on which
the Common Stock is then listed or quoted as reported by Bloomberg L.P. (based on a Trading Day from 9:30 a.m. (New York City
time) to 4:02 p.m. (New York City time)), (b) if OTCQB or OTCQX is not a Trading Market, the volume weighted average price of
the Common Stock for such date (or the nearest preceding date) on OTCQB or OTCQX as applicable, (c) if the Common Stock is not
then listed or quoted for trading on OTCQB or OTCQX and if prices for the Common Stock are then reported on The Pink Open Market
(or a similar organization or agency succeeding to its functions of reporting prices), the most recent bid price per share of
the Common Stock so reported, or (d) in all other cases, the fair market value of a share of Common Stock as determined by
an independent appraiser selected in good faith by the Holders of a majority in interest of the Securities then outstanding and
reasonably acceptable to the Company, the fees and expenses of which shall be paid by the Company.

 

    3

     

    

 

If
Warrant Shares are issued in such a cashless exercise, the parties acknowledge and agree that in accordance with Section 3(a)(9)
of the Securities Act, the Warrant Shares shall take on the characteristics of the Warrants being exercised, and the holding period
of the Warrant Shares being issued may be tacked on to the holding period of this Warrant. The Company agrees not to take any
position contrary to this Section 2(c).

 

Notwithstanding
anything herein to the contrary, on the Termination Date, this Warrant shall be automatically exercised via cashless exercise
pursuant to this Section 2(c).

 

d)
Mechanics of Exercise.

 

i.
Delivery of Warrant Shares Upon Exercise. The Company shall cause the Warrant Shares purchased hereunder to be transmitted
by the Transfer Agent to the Holder by crediting the account of the Holder’s or its designee’s balance account with
The Depository Trust Company through its Deposit or Withdrawal at Custodian system (“DWAC”) if the Company
is then a participant in such system and either (A) there is an effective registration statement permitting the issuance of the
Warrant Shares to or resale of the Warrant Shares by the Holder or (B) the Warrant Shares are eligible for resale by the Holder
without volume or manner of sale limitations pursuant to Rule 144 (assuming cashless exercise of the Warrants), and otherwise
by physical delivery of a certificate, registered in the Company’s share register in the name of the Holder or its designee,
for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise to the address specified by the Holder
in the Notice of Exercise by the date that is the earliest of (i) two (2) Trading Days (ii) the number of days comprising the
Standard Settlement Period, in each case after the delivery to the Company of the Notice of Exercise and (iii) one (1) Trading
Day after delivery of the aggregate Exercise Price to the Company (such date, the “Warrant Share Delivery Date”).
Upon delivery of the Notice of Exercise, the Holder shall be deemed for all corporate purposes to have become the holder of record
of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date of delivery of the Warrant
Shares, provided that payment of the aggregate Exercise Price (other than in the case of a cashless exercise) is received by the
Warrant Share Delivery Date. If the Company fails for any reason to deliver to the Holder the Warrant Shares subject to a Notice
of Exercise by the Warrant Share Delivery Date, the Company shall pay to the Holder, in cash, as liquidated damages and not as
a penalty, for each $1,000 of Warrant Shares subject to such exercise (based on the VWAP of the Common Stock on the date of the
applicable Notice of Exercise), $10 per Trading Day (increasing to $20 per Trading Day on the fifth Trading Day after such liquidated
damages begin to accrue) for each Trading Day after such Warrant Share Delivery Date until such Warrant Shares are delivered or
the Holder rescinds such exercise. The Company agrees to maintain a transfer agent that is a participant in the FAST program so
long as this Warrant remains outstanding and exercisable. As used herein, “Standard Settlement Period” means
the standard settlement period, expressed in a number of Trading Days, on the Company’s primary Trading Market with respect
to the Common Stock as in effect on the date of delivery of the Notice of Exercise.

 

    4

     

    

 

ii.
Delivery of New Warrants Upon Exercise. If this Warrant shall have been exercised in part, the Company shall, at the request
of a Holder and upon surrender of this Warrant certificate, at the time of delivery of the Warrant Shares, deliver to the Holder
a new Warrant evidencing the rights of the Holder to purchase the unpurchased Warrant Shares called for by this Warrant, which
new Warrant shall in all other respects be identical with this Warrant.

 

iii.
Rescission Rights. If the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares pursuant
to Section 2(d)(i) by the Warrant Share Delivery Date, then the Holder will have the right to rescind such exercise.

 

iv.
Compensation for Buy-In on Failure to Timely Deliver Warrant Shares Upon Exercise. In addition to any other rights available
to the Holder, if the Company fails to cause the Transfer Agent to transmit to the Holder the Warrant Shares in accordance with
the provisions of Section 2(d)(i) above pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such
date the Holder is required by its broker to purchase (in an open market transaction or otherwise) or the Holder’s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which
the Holder anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (A) pay in cash to
the Holder the amount, if any, by which (x) the Holder’s total purchase price (including brokerage commissions, if any)
for the shares of Common Stock so purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that
the Company was required to deliver to the Holder in connection with the exercise at issue times (2) the price at which the sell
order giving rise to such purchase obligation was executed, and (B) at the option of the Holder, either reinstate the portion
of the Warrant and equivalent number of Warrant Shares for which such exercise was not honored (in which case such exercise shall
be deemed rescinded) or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company
timely complied with its exercise and delivery obligations hereunder. For example, if the Holder purchases Common Stock having
a total purchase price of $11,000 to cover a Buy-In with respect to an attempted exercise of shares of Common Stock with an aggregate
sale price giving rise to such purchase obligation of $10,000, under clause (A) of the immediately preceding sentence the Company
shall be required to pay the Holder $1,000. The Holder shall provide the Company written notice indicating the amounts payable
to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the amount of such loss. Nothing herein shall
limit a Holder’s right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation,
a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver shares
of Common Stock upon exercise of the Warrant as required pursuant to the terms hereof.

 

    5

     

    

 

v.
No Fractional Shares or Scrip. No fractional shares or scrip representing fractional shares shall be issued upon the exercise
of this Warrant. As to any fraction of a share which the Holder would otherwise be entitled to purchase upon such exercise, the
Company shall, at its election, either pay a cash adjustment in respect of such final fraction in an amount equal to such fraction
multiplied by the Exercise Price or round up to the next whole share.

 

vi.
Charges, Taxes and Expenses. Issuance of Warrant Shares shall be made without charge to the Holder for any issue or transfer
tax or other incidental expense in respect of the issuance of such Warrant Shares, all of which taxes and expenses shall be paid
by the Company, and such Warrant Shares shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event that Warrant Shares are to be issued in a name other than the
name of the Holder, this Warrant when surrendered for exercise shall be accompanied by the Assignment Form attached hereto duly
executed by the Holder and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for
any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day processing of any Notice
of Exercise and all fees to the Depository Trust Company (or another established clearing corporation performing similar functions)
required for same-day electronic delivery of the Warrant Shares.

 

vii.
Closing of Books. The Company will not close its stockholder books or records in any manner which prevents the timely exercise
of this Warrant, pursuant to the terms hereof.

 

    6

     

    

 

e)
Holder’s Exercise Limitations. The Company shall not effect any exercise of this Warrant, and a Holder shall not
have the right to exercise any portion of this Warrant, pursuant to Section 2 or otherwise, to the extent that after giving effect
to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s
Affiliates, and any other Persons acting as a group together with the Holder or any of the Holder’s Affiliates (such Persons,
“Attribution Parties”)), would beneficially own in excess of the Beneficial Ownership Limitation (as defined
below). For purposes of the foregoing sentence, the number of shares of Common Stock beneficially owned by the Holder and its
Affiliates and Attribution Parties shall include the number of shares of Common Stock issuable upon exercise of this Warrant with
respect to which such determination is being made, but shall exclude the number of shares of Common Stock which would be issuable
upon (i) exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder or any of its Affiliates
or Attribution Parties and (ii) exercise or conversion of the unexercised or nonconverted portion of any other securities of the
Company (including, without limitation, any other Common Stock Equivalents) subject to a limitation on conversion or exercise
analogous to the limitation contained herein beneficially owned by the Holder or any of its Affiliates or Attribution Parties.
Except as set forth in the preceding sentence, for purposes of this Section 2(e), beneficial ownership shall be calculated in
accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder, it being acknowledged
by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of
the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent
that the limitation contained in this Section 2(e) applies, the determination of whether this Warrant is exercisable (in relation
to other securities owned by the Holder together with any Affiliates and Attribution Parties) and of which portion of this Warrant
is exercisable shall be in the sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed to be
the Holder’s determination of whether this Warrant is exercisable (in relation to other securities owned by the Holder together
with any Affiliates and Attribution Parties) and of which portion of this Warrant is exercisable, in each case subject to the
Beneficial Ownership Limitation, and the Company shall have no obligation to verify or confirm the accuracy of such determination.
In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d)
of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 2(e), in determining the
number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as reflected
in (A) the Company’s most recent periodic or annual report filed with the Commission, as the case may be, (B) a more recent
public announcement by the Company or (C) a more recent written notice by the Company or the Transfer Agent setting forth the
number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within one (1) Trading
Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the
Company, including this Warrant, by the Holder or its Affiliates or Attribution Parties since the date as of which such number
of outstanding shares of Common Stock was reported. The “Beneficial Ownership Limitation” shall be [4.99%/9.99%]
of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock
issuable upon exercise of this Warrant. The Holder, upon notice to the Company, may increase or decrease the Beneficial Ownership
Limitation provisions of this Section 2(e), provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock upon
exercise of this Warrant held by the Holder and the provisions of this Section 2(e) shall continue to apply. Any increase in the
Beneficial Ownership Limitation will not be effective until the 61st day after such notice is delivered to the Company. The provisions
of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section
2(e) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership
Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation.
The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

 

    7

     

    

 

Section
3.Certain Adjustments.

 

a)
Stock Dividends and Splits. If the Company, at any time while this Warrant is outstanding: (i) pays a stock dividend or
otherwise makes a distribution or distributions on shares of its Common Stock or any other equity or equity equivalent securities
payable in shares of Common Stock (which, for avoidance of doubt, shall not include any shares of Common Stock issued by the Company
upon exercise of this Warrant), (ii) subdivides outstanding shares of Common Stock into a larger number of shares, (iii) combines
(including by way of reverse stock split) outstanding shares of Common Stock into a smaller number of shares, or (iv) issues by
reclassification of shares of the Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding treasury shares,
if any) outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding
immediately after such event, and the number of shares issuable upon exercise of this Warrant shall be proportionately adjusted
such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made pursuant to this Section 3(a)
shall become effective immediately after the record date for the determination of stockholders entitled to receive such dividend
or distribution and shall become effective immediately after the effective date in the case of a subdivision, combination or re-classification.

 

b)
Reserved. 

 

c)
Subsequent Rights Offerings. In addition to any adjustments pursuant to Section 3(a) above, if at any time the Company
grants, issues or sells any Common Stock Equivalents or rights to purchase stock, warrants, securities or other property pro rata
to the record holders of any class of shares of Common Stock (the “Purchase Rights”), then the Holder will
be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could
have acquired if the Holder had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the
date as of which the record holders of shares of Common Stock are to be determined for the grant, issue or sale of such Purchase
Rights (provided, however, to the extent that the Holder’s right to participate in any such Purchase Right would result
in the Holder exceeding the Beneficial Ownership Limitation, then the Holder shall not be entitled to participate in such Purchase
Right to such extent (or beneficial ownership of such shares of Common Stock as a result of such Purchase Right to such extent)
and such Purchase Right to such extent shall be held in abeyance for the Holder until such time, if ever, as its right thereto
would not result in the Holder exceeding the Beneficial Ownership Limitation).

 

    8

     

    

 

d)
Pro Rata Distributions. During such time as this Warrant is outstanding, if the Company shall declare or make any dividend
or other distribution of its assets (or rights to acquire its assets) to holders of shares of Common Stock, by way of return of
capital or otherwise (including, without limitation, any distribution of cash, stock or other securities, property or options
by way of a dividend, spin off, reclassification, corporate rearrangement, scheme of arrangement or other similar transaction)
(a “Distribution”), at any time after the issuance of this Warrant, then, in each such case, the Holder shall
be entitled to participate in such Distribution to the same extent that the Holder would have participated therein if the Holder
had held the number of shares of Common Stock acquirable upon complete exercise of this Warrant (without regard to any limitations
on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before the date of which a
record is taken for such Distribution, or, if no such record is taken, the date as of which the record holders of shares of Common
Stock are to be determined for the participation in such Distribution (provided, however, to the extent that the
Holder's right to participate in any such Distribution would result in the Holder exceeding the Beneficial Ownership Limitation,
then the Holder shall not be entitled to participate in such Distribution to such extent (or in the beneficial ownership of any
shares of Common Stock as a result of such Distribution to such extent) and the portion of such Distribution shall be held in
abeyance for the benefit of the Holder until such time, if ever, as its right thereto would not result in the Holder exceeding
the Beneficial Ownership Limitation). To the extent that this Warrant has not been partially or completely exercised at the time
of such Distribution, such portion of the Distribution shall be held in abeyance for the benefit of the Holder until the Holder
has exercised this Warrant.

 

    9

     

    

 

e)
Fundamental Transaction. If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in
one or more related transactions effects any merger or consolidation of the Company with or into another Person, (ii) the Company,
directly or indirectly, effects any sale, lease, license, assignment, transfer, conveyance or other disposition of all or substantially
all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange
offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell,
tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of
the outstanding Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification,
reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly, in
one or more related transactions consummates a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off, merger or scheme of arrangement) with another Person or group of Persons
whereby such other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares
of Common Stock held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons
making or party to, such stock or share purchase agreement or other business combination) (each a “Fundamental Transaction”),
then, upon any subsequent exercise of this Warrant, the Holder shall have the right to receive, for each Warrant Share that would
have been issuable upon such exercise immediately prior to the occurrence of such Fundamental Transaction, at the option of the
Holder (without regard to any limitation in Section 2(e) on the exercise of this Warrant), the number of shares of Common Stock
of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and any additional consideration
(the “Alternate Consideration”) receivable as a result of such Fundamental Transaction by a holder of the number
of shares of Common Stock for which this Warrant is exercisable immediately prior to such Fundamental Transaction (without regard
to any limitation in Section 2(e) on the exercise of this Warrant). For purposes of any such exercise, the determination of the
Exercise Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
issuable in respect of one share of Common Stock in such Fundamental Transaction, and the Company shall apportion the Exercise
Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received
in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon
any exercise of this Warrant following such Fundamental Transaction. Notwithstanding anything to the contrary, in the event of
a Fundamental Transaction, the Company or any Successor Entity (as defined below) shall, at the Holder’s option, exercisable
at any time concurrently with, or within 30 days after, the consummation of the Fundamental Transaction (or, if later, the date
of the public announcement of the applicable Fundamental Transaction), purchase this Warrant from the Holder by paying to the
Holder an amount of cash equal to the Black Scholes Value of the remaining unexercised portion of this Warrant on the date of
the consummation of such Fundamental Transaction; provided, however, if the Fundamental Transaction is not within
the Company's control, including not approved by the Company's Board of Directors, the Holder shall only be entitled to receive
from the Company or any Successor Entity, as of the date of consummation of such Fundamental Transaction, the same type or form
of consideration (and in the same proportion), at the Black Scholes Value (as defined below) of the unexercised portion of this
Warrant, that is being offered and paid to the holders of Common Stock of the Company in connection with the Fundamental Transaction,
whether that consideration be in the form of cash, stock or any combination thereof, or whether the holders of Common Stock are
given the choice to receive from among alternative forms of consideration in connection with the Fundamental Transaction. “Black
Scholes Value” means the value of this Warrant based on the Black Scholes Option Pricing Model obtained from the “OV”
function on Bloomberg, L.P. (“Bloomberg”) determined as of the day of consummation of the applicable Fundamental
Transaction for pricing purposes and reflecting (A) a risk-free interest rate corresponding to the U.S. Treasury rate for a period
equal to the time between the date of the public announcement of the applicable Fundamental Transaction and the Termination Date,
(B) an expected volatility equal to the greater of 100% and the 100 day volatility obtained from the HVT function on Bloomberg
(determined utilizing a 365 day annualization factor) as of the Trading Day immediately following the public announcement of the
applicable Fundamental Transaction, (C) the underlying price per share used in such calculation shall be the greater of (i) the
sum of the price per share being offered in cash, if any, plus the value of any non-cash consideration, if any, being offered
in such Fundamental Transaction and (ii) the greater of (x) the last VWAP immediately prior to the public announcement of such
Fundamental Transaction and (y) the last VWAP immediately prior to the consummation of such Fundamental Transaction and (D) a
remaining option time equal to the time between the date of the public announcement of the applicable Fundamental Transaction
and the Termination Date. The payment of the Black Scholes Value will be made by wire transfer of immediately available funds
(or by delivery of such other consideration, as applicable) within five Business Days of the Holder’s election (or, if later,
on the effective date of the Fundamental Transaction). The Company shall cause any successor entity in a Fundamental Transaction
in which the Company is not the survivor (the “Successor Entity”) to assume in writing all of the obligations
of the Company under this Warrant in accordance with the provisions of this Section 3(e) pursuant to written agreements in form
and substance reasonably satisfactory to the Holder and approved by the Holder (without unreasonable delay) prior to such Fundamental
Transaction and shall, at the option of the Holder, deliver to the Holder in exchange for this Warrant a security of the Successor
Entity evidenced by a written instrument substantially similar in form and substance to this Warrant which is exercisable for
a corresponding number of shares of capital stock of such Successor Entity (or its parent entity) equivalent to the shares of
Common Stock acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this
Warrant) prior to such Fundamental Transaction, and with an exercise price which applies the exercise price hereunder to such
shares of capital stock (but taking into account the relative value of the shares of Common Stock pursuant to such Fundamental
Transaction and the value of such shares of capital stock, such number of shares of capital stock and such exercise price being
for the purpose of protecting the economic value of this Warrant immediately prior to the consummation of such Fundamental Transaction),
and which is reasonably satisfactory in form and substance to the Holder. Upon the occurrence of any such Fundamental Transaction,
the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction,
the provisions of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise
every right and power of the Company and shall assume all of the obligations of the Company under this Warrant with the same effect
as if such Successor Entity had been named as the Company herein.

 

    10

     

    

 

f)
Calculations. All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th of a share,
as the case may be. For purposes of this Section 3, the number of shares of Common Stock deemed to be issued and outstanding as
of a given date shall be the sum of the number of shares of Common Stock (excluding treasury shares, if any) issued and outstanding.

 

g)
Notice to Holder.

 

i.
Adjustment to Exercise Price. Whenever the Exercise Price is adjusted pursuant to any provision of this Section 3, the
Company shall promptly deliver to the Holder by facsimile or email a notice setting forth the Exercise Price after such adjustment
and any resulting adjustment to the number of Warrant Shares and setting forth a brief statement of the facts requiring such adjustment.

 

ii.
Notice to Allow Exercise by Holder. If (A) the Company shall declare a dividend (or any other distribution in whatever
form) on the Common Stock, (B) the Company shall declare a special nonrecurring cash dividend on or a redemption of the Common
Stock, (C) the Company shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or
purchase any shares of capital stock of any class or of any rights, (D) the approval of any stockholders of the Company shall
be required in connection with any reclassification of the Common Stock, any consolidation or merger to which the Company is a
party, any sale or transfer of all or substantially all of the assets of the Company, or any compulsory share exchange whereby
the Common Stock is converted into other securities, cash or property, or (E) the Company shall authorize the voluntary or involuntary
dissolution, liquidation or winding up of the affairs of the Company, then, in each case, the Company shall cause to be delivered
by facsimile or email to the Holder at its last facsimile number or email address as it shall appear upon the Warrant Register
of the Company, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice stating
(x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend,
distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification, consolidation,
merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected that
holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure
to deliver such notice or any defect therein or in the delivery thereof shall not affect the validity of the corporate action
required to be specified in such notice. To the extent that any notice provided in this Warrant constitutes, or contains, material,
non-public information regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with
the Commission pursuant to a Current Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the
period commencing on the date of such notice to the effective date of the event triggering such notice except as may otherwise
be expressly set forth herein.

 

    11

     

    

 

Section
4.Transfer of Warrant.

 

a)
Transferability. Subject to compliance with any applicable securities laws and the conditions set forth in Section 4(d)
hereof, this Warrant and all rights hereunder (including, without limitation, any registration rights) are transferable, in whole
or in part, upon surrender of this Warrant at the principal office of the Company or its designated agent, together with a written
assignment of this Warrant substantially in the form attached hereto duly executed by the Holder or its agent or attorney and
funds sufficient to pay any transfer taxes payable upon the making of such transfer. Upon such surrender and, if required, such
payment, the Company shall execute and deliver a new Warrant or Warrants in the name of the assignee or assignees, as applicable,
and in the denomination or denominations specified in such instrument of assignment, and shall issue to the assignor a new Warrant
evidencing the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled. Notwithstanding anything
herein to the contrary, the Holder shall not be required to physically surrender this Warrant to the Company unless the Holder
has assigned this Warrant in full, in which case, the Holder shall surrender this Warrant to the Company within three (3) Trading
Days of the date on which the Holder delivers an assignment form to the Company assigning this Warrant in full. The Warrant, if
properly assigned in accordance herewith, may be exercised by a new holder for the purchase of Warrant Shares without having a
new Warrant issued.

 

b)
New Warrants. This Warrant may be divided or combined with other Warrants upon presentation hereof at the aforesaid office
of the Company, together with a written notice specifying the names and denominations in which new Warrants are to be issued,
signed by the Holder or its agent or attorney. Subject to compliance with Section 4(a), as to any transfer which may be involved
in such division or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange for the Warrant or
Warrants to be divided or combined in accordance with such notice. All Warrants issued on transfers or exchanges shall be dated
the Issue Date of this Warrant and shall be identical with this Warrant except as to the number of Warrant Shares issuable pursuant
thereto.

 

c)
Warrant Register. The Company shall register this Warrant, upon records to be maintained by the Company for that purpose
(the “Warrant Register”), in the name of the record Holder hereof from time to time. The Company may deem and
treat the registered Holder of this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
to the Holder, and for all other purposes, absent actual notice to the contrary.

 

d)
Representation by the Holder. The Holder, by the acceptance hereof, represents and warrants that it is acquiring this Warrant
and, upon any exercise hereof, will acquire the Warrant Shares issuable upon such exercise, for its own account and not with a
view to or for distributing or reselling such Warrant Shares or any part thereof in violation of the Securities Act or any applicable
state securities law, except pursuant to sales registered or exempted under the Securities Act.

 

    12

     

    

 

Section
5.Miscellaneous.

 

a)
No Rights as Stockholder Until Exercise; No Settlement in Cash. This Warrant does not entitle the Holder to any voting
rights, dividends or other rights as a stockholder of the Company prior to the exercise hereof as set forth in Section 2(d)(i),
except as expressly set forth in Section 3. Without limiting the rights of a Holder to receive Warrant Shares on a “cashless
exercise,” and to receive the cash payments contemplated pursuant to Sections 2(d)(i) and 2(d)(iv), in no event will the
Company be required to net cash settle a Warrant exercise.

 

b)
Loss, Theft, Destruction or Mutilation of Warrant. The Company covenants that upon receipt by the Company of evidence reasonably
satisfactory to it of the loss, theft, destruction or mutilation of this Warrant or any stock certificate relating to the Warrant
Shares, and in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to it (which, in the case
of the Warrant, shall not include the posting of any bond), and upon surrender and cancellation of such Warrant or stock certificate,
if mutilated, the Company will make and deliver a new Warrant or stock certificate of like tenor and dated as of such cancellation,
in lieu of such Warrant or stock certificate.

 

c)
Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking of any action or the expiration of any right
required or granted herein shall not be a Business Day, then, such action may be taken or such right may be exercised on the next
succeeding Business Day.

 

d)
Authorized Shares.

 

The
Company covenants that, during the period the Warrant is outstanding, it will reserve from its authorized and unissued Common
Stock a sufficient number of shares to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
under this Warrant. The Company further covenants that its issuance of this Warrant shall constitute full authority to its officers
who are charged with the duty of issuing the necessary Warrant Shares upon the exercise of the purchase rights under this Warrant.
The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided
herein without violation of any applicable law or regulation, or of any requirements of the Trading Market upon which the Common
Stock may be listed. The Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase rights
represented by this Warrant will, upon exercise of the purchase rights represented by this Warrant and payment for such Warrant
Shares in accordance herewith, be duly authorized, validly issued, fully paid and nonassessable and free from all taxes, liens
and charges created by the Company in respect of the issue thereof (other than taxes in respect of any transfer occurring contemporaneously
with such issue).

 

    13

     

    

 

Except
and to the extent as waived or consented to by the Holder, the Company shall not by any action, including, without limitation,
amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution,
issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the
terms of this Warrant, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all
such actions as may be necessary or appropriate to protect the rights of Holder as set forth in this Warrant against impairment.
Without limiting the generality of the foregoing, the Company will (i) not increase the par value of any Warrant Shares above
the amount payable therefor upon such exercise immediately prior to such increase in par value, (ii) take all such action as may
be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Warrant Shares
upon the exercise of this Warrant and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
or consents from any public regulatory body having jurisdiction thereof, as may be, necessary to enable the Company to perform
its obligations under this Warrant.

 

Before
taking any action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or
in the Exercise Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be
necessary from any public regulatory body or bodies having jurisdiction thereof.

 

e)
Jurisdiction. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflict of laws thereof. Each party agrees that all legal proceedings concerning the interpretation, enforcement
and defense of this Warrant shall be commenced in the state and federal courts sitting in the City of New York, Borough of Manhattan
(the “New York Courts”). Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the
New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of such New York Courts, or such New York Courts are improper or inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served
in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with
evidence of delivery) to such party at the address in effect for notices to it under this Warrant and agrees that such service
shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit
in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or
proceeding to enforce any provisions of this Warrant, the prevailing party in such action, suit or proceeding shall be reimbursed
by the other party for their reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation
and prosecution of such action or proceeding.

 

f)
Restrictions. The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant, if not registered,
and the Holder does not utilize cashless exercise, will have restrictions upon resale imposed by state and federal securities
laws.

 

    14

     

    

 

g)
Nonwaiver and Expenses. No course of dealing or any delay or failure to exercise any right hereunder on the part of Holder
shall operate as a waiver of such right or otherwise prejudice the Holder’s rights, powers or remedies. Without limiting
any other provision of this Warrant, if the Company willfully and knowingly fails to comply with any provision of this Warrant,
which results in any material damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to
cover any costs and expenses including, but not limited to, reasonable attorneys’ fees, including those of appellate proceedings,
incurred by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies
hereunder.

 

h)
Notices. Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without
limitation, any Notice of Exercise, shall be in writing and delivered personally, by facsimile or e-mail, or sent by a nationally
recognized overnight courier service, addressed to the Company, at the address set forth above Attention: _________________,
facsimile number _______________, email address _______________, or such other facsimile number, email address or address as the
Company may specify for such purposes by notice to the Holders. Any and all notices or other communications or deliveries to be
provided by the Company hereunder shall be in writing and delivered personally, by facsimile or email, or sent by a nationally
recognized overnight courier service addressed to each Holder at the facsimile number, email address or address of such Holder
appearing on the books of the Company. Any notice or other communication or deliveries hereunder shall be deemed given and effective
on the earliest of (i) the date of transmission, if such notice or communication is delivered via facsimile or email at the facsimile
number or email address set forth in this Section prior to 5:30 p.m. (New York City time) on any date, (ii) the next Trading Day
after the date of transmission, if such notice or communication is delivered via facsimile or email at the facsimile number or
email address set forth in this Section on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any
Trading Day, (iii) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier
service, or (iv) upon actual receipt by the party to whom such notice is required to be given. To the extent that any notice provided
hereunder constitutes, or contains, material, non-public information regarding the Company or any subsidiaries, the Company shall
simultaneously file such notice with the Commission pursuant to a Current Report on Form 8-K.

 

i)
Limitation of Liability. No provision hereof, in the absence of any affirmative action by the Holder to exercise this Warrant
to purchase Warrant Shares, and no enumeration herein of the rights or privileges of the Holder, shall give rise to any liability
of the Holder for the purchase price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
by the Company or by creditors of the Company.

 

    15

     

    

 

j)
Remedies. The Holder, in addition to being entitled to exercise all rights granted by law, including recovery of damages,
will be entitled to specific performance of its rights under this Warrant. The Company agrees that monetary damages would not
be adequate compensation for any loss incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
to waive and not to assert the defense in any action for specific performance that a remedy at law would be adequate.

 

k)
Successors and Assigns. Subject to applicable securities laws, this Warrant and the rights and obligations evidenced hereby
shall inure to the benefit of and be binding upon the successors and permitted assigns of the Company and the successors and permitted
assigns of Holder. The provisions of this Warrant are intended to be for the benefit of any Holder from time to time of this Warrant
and shall be enforceable by the Holder or holder of Warrant Shares.

 

l)
Amendment. This Warrant may be modified or amended or the provisions hereof waived with the written consent of the Company
and the Holder.

 

m)
Severability. Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective
and valid under applicable law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such
provision shall be ineffective to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions
or the remaining provisions of this Warrant.

 

n)
Headings. The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be
deemed a part of this Warrant.

 

********************

 

(Signature
Page Follows)

 

    16

     

    

 

IN
WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of the date first
above indicated.

 

	 	Citius
                                         Pharmaceuticals, Inc.

	 	 
	 	By:	                      

	 	 	Name:
	 	 	Title:

 

    17

     

    

 

NOTICE
OF EXERCISE

 

To:Citius
Pharmaceuticals, Inc.

 

(1)
The undersigned hereby elects to purchase ________ Warrant Shares of the Company pursuant to the terms of the attached Warrant
(only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer
taxes, if any.

 

(2)
Payment shall take the form of (check applicable box):

 

☐ in
lawful money of the United States; or

 

☐ if
permitted the cancellation of such number of Warrant Shares as is necessary, in accordance with the formula set forth in subsection
2(c), to exercise this Warrant with respect to the maximum number of Warrant Shares purchasable pursuant to the cashless exercise
procedure set forth in subsection 2(c).

 

(3)
Please issue said Warrant Shares in the name of the undersigned or in such other name as is specified below:

 

_______________________________

 

The
Warrant Shares shall be delivered to the following DWAC Account Number:

 

 

_______________________________

 

 

_______________________________

 

 

_______________________________

 

(4)
Accredited Investor. The undersigned is an “accredited investor” as defined in Regulation D promulgated under the
Securities Act of 1933, as amended.

 

[SIGNATURE
OF HOLDER]

 

Name
of Investing Entity: ________________________________________________________________________

 

Signature
of Authorized Signatory of Investing Entity: _________________________________________________

 

Name
of Authorized Signatory: ___________________________________________________________________

 

Title
of Authorized Signatory: ____________________________________________________________________

 

Date:
________________________________________________________________________________________

 

     

     

    

 

EXHIBIT
B

 

ASSIGNMENT
FORM

 

(To
assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

 

FOR
VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

 

	Name:	______________________________________
	 	(Please
    Print)
	 	 
	Address:	______________________________________
	 

         

        Phone
        Number:

         

        Email
        Address:
	(Please
                                         Print)

         

        ______________________________________

         

        ______________________________________

	 	 
	Dated:
    _______________ __, ______	 
	 	 
	Holder’s
    Signature: _____________________	 
	 	 
	Holder’s
    Address: _____________________

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00320-of-00352.parquet"}]]